{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:28:41Z","timestamp":1781108921733,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-025-04126-y","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:54:09Z","timestamp":1763549649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effect of para-aortic lymphadenectomy on survival in early stage endometrioid grade 3 and non-endometrioid endometrial cancers"],"prefix":"10.1186","volume":"25","author":[{"given":"Yakup","family":"Yalcin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahadir","family":"Kosan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serenat","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Sakinmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemal","family":"Ozerkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"1","key":"4126_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4126_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","volume":"31","author":"N Concin","year":"2021","unstructured":"Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31(1):12\u201339. https:\/\/doi.org\/10.1136\/ijgc-2020-002230.","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"4126_CR3","doi-asserted-by":"publisher","first-page":"e423","DOI":"10.1016\/S1470-2045(25)00560-1","volume":"26","author":"N Concin","year":"2025","unstructured":"Concin N, Matias-Guiu X, Cibula D, Colombo N, Creutzberg CL, Ledermann J, et al. ESGO-ESTRO-ESP guidelines for the management of patients with endometrial carcinoma: update 2025. Lancet Oncol. 2025;26(8):e423\u201335. https:\/\/doi.org\/10.1016\/S1470-2045(25)00560-1.","journal-title":"Lancet Oncol"},{"issue":"1","key":"4126_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15(1):10\u20137. https:\/\/doi.org\/10.1016\/0090-8258(83)90111-7.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"4126_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ygyno.2011.07.030","volume":"124","author":"MA Voss","year":"2012","unstructured":"Voss MA, Ganesan R, Ludeman L, McCarthy K, Gornall R, Schaller G, et al. Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation. Gynecol Oncol. 2012;124(1):15\u201320. https:\/\/doi.org\/10.1016\/j.ygyno.2011.07.030.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"4126_CR6","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2023.34.e85","volume":"34","author":"JS Berek","year":"2023","unstructured":"Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, et al. FIGO staging of endometrial cancer: 2023. J Gynecol Oncol. 2023;34(5):e85. https:\/\/doi.org\/10.3802\/jgo.2023.34.e85.","journal-title":"J Gynecol Oncol"},{"key":"4126_CR7","unstructured":"NCCN. Clinical Practice Guidelines in Oncology (Nccn Guidelines) Version 3. 2025. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/uterine.pdf Accessed 1 Aug 2025."},{"issue":"9721","key":"4126_CR8","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0140-6736(09)62002-X","volume":"375","author":"Y Todo","year":"2010","unstructured":"Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010;375(9721):1165\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(09)62002-X.","journal-title":"Lancet"},{"issue":"1","key":"4126_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ygyno.2022.08.009","volume":"167","author":"YL Lai","year":"2022","unstructured":"Lai YL, Chang CS, Chang K, Kim HS, Chen J, Cheng WF, et al. Does para-aortic lymphadenectomy improve survival in pathologically diagnosed early-stage grade 3 endometrioid and non-endometrioid endometrial cancers? A retrospective cohort study in Korea and Taiwan. Gynecol Oncol. 2022;167(1):65\u201372. https:\/\/doi.org\/10.1016\/j.ygyno.2022.08.009.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"4126_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61061079","volume":"61","author":"YL Lai","year":"2025","unstructured":"Lai YL, Seo JH, Chang K, Kim HS, Chen J, Yang TS, et al. Impact of para-aortic lymphadenectomy on clinically FIGO stage IIIC1 high-grade endometrial cancer: a retrospective cohort study from two tertiary centers in Korea and Taiwan. Medicina (B Aires). 2025;61(6):1079. https:\/\/doi.org\/10.3390\/medicina61061079.","journal-title":"Medicina (B Aires)"},{"key":"4126_CR11","doi-asserted-by":"publisher","unstructured":"Seagle BL, Gilchrist-Scott D, Graves S, Strohl AE, Nieves-Neira W, Shahabi S. Association of lymph node count and overall survival in node-Negative endometrial cancers. JCO Clin Cancer Inf. 2017;1. https:\/\/doi.org\/10.1200\/CCI.16.00064.","DOI":"10.1200\/CCI.16.00064"},{"issue":"2","key":"4126_CR12","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/ijgc-2018-000084","volume":"29","author":"L Volpi","year":"2019","unstructured":"Volpi L, Sozzi G, Capozzi VA, Ricco\u2019 M, Merisio C, Di Serio M. Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single institution experience. Int J Gynecol Cancer. 2019;29(2):312\u20139. https:\/\/doi.org\/10.1136\/ijgc-2018-000084.","journal-title":"Int J Gynecol Cancer"},{"key":"4126_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/CCI.17.00028","volume":"1","author":"BL Seagle","year":"2017","unstructured":"Seagle BL, Kocherginsky M, Shahabi S. Association of pelvic and Para-Aortic lymphadenectomy with survival in stage I endometrioid endometrial cancer: matched cohort analyses from the National cancer database. JCO Clin Cancer Inf. 2017;1:1\u201314. https:\/\/doi.org\/10.1200\/CCI.17.00028.","journal-title":"JCO Clin Cancer Inf"},{"issue":"5","key":"4126_CR14","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1245\/s10434-010-1472-7","volume":"18","author":"SY Tong","year":"2011","unstructured":"Tong SY, Lee JM, Lee JK, Kim JW, Cho CH, Kim SM, et al. Efficacy of para-aortic lymphadenectomy in early-stage endometrioid uterine corpus cancer. Ann Surg Oncol. 2011;18(5):1425\u201330. https:\/\/doi.org\/10.1245\/s10434-010-1472-7.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"4126_CR15","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1007\/s00432-017-2508-1","volume":"143","author":"T Papathemelis","year":"2017","unstructured":"Papathemelis T, Scharl S, Kronberger K, Gerken M, Scharl A, Pauer A, et al. Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis. J Cancer Res Clin Oncol. 2017;143(12):2555\u201362. https:\/\/doi.org\/10.1007\/s00432-017-2508-1.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"4126_CR16","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ygyno.2018.03.046","volume":"149","author":"S Venigalla","year":"2018","unstructured":"Venigalla S, Chowdhry AK, Shalowitz DI. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers. Gynecol Oncol. 2018;149(3):531\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2018.03.046.","journal-title":"Gynecol Oncol"},{"issue":"9658","key":"4126_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","volume":"373","author":"H Kitchener","year":"2009","unstructured":"ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373(9658):125\u201336. https:\/\/doi.org\/10.1016\/S0140-6736(08)61766-3.","journal-title":"Lancet"},{"issue":"23","key":"4126_CR18","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1093\/jnci\/djn397","volume":"100","author":"P Benedetti Panici","year":"2008","unstructured":"Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100(23):1707\u201316. https:\/\/doi.org\/10.1093\/jnci\/djn397.","journal-title":"J Natl Cancer Inst"},{"key":"4126_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1295613","volume":"2020","author":"D Vatansever","year":"2020","unstructured":"Vatansever D, Sozen H, Sahin Ersoy G, Giray B, Topuz S, Iyibozkurt AC, et al. Effect of lymphadenectomy on survival in early-stage type II endometrial carcinoma and carcinosarcoma. J Oncol. 2020;2020:1295613. https:\/\/doi.org\/10.1155\/2020\/1295613.","journal-title":"J Oncol"},{"issue":"9213","key":"4126_CR20","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/s0140-6736(00)02139-5","volume":"355","author":"CL Creutzberg","year":"2000","unstructured":"Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, W\u00e1rl\u00e1m-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study Group. Post operative radiation therapy in endometrial carcinoma. Lancet. 2000;355(9213):1404\u201311. https:\/\/doi.org\/10.1016\/s0140-6736(00)02139-5.","journal-title":"Lancet"},{"issue":"21","key":"4126_CR21","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1200\/JCO.18.01575","volume":"37","author":"ME Randall","year":"2019","unstructured":"Randall ME, Filiaci V, McMeekin DS, von Gruenigen V, Huang H, Yashar CM, et al. Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high-risk early stage endometrial cancer. J Clin Oncol. 2019;37(21):1810\u20138. https:\/\/doi.org\/10.1200\/JCO.18.01575.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4126_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/13645706.2020","volume":"31","author":"G Gitas","year":"2022","unstructured":"Gitas G, Freytag D, Allahqoli L, Baum S, Rody A, Maass N, et al. Lymphadenectomy in endometrial cancer-achieving more with less? Minim Invasive Ther Allied Technol. 2022;31(4):531\u20139. https:\/\/doi.org\/10.1080\/13645706.2020.","journal-title":"Minim Invasive Ther Allied Technol"},{"issue":"12","key":"4126_CR23","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1136\/ijgc-2024-005769","volume":"34","author":"S Cosma","year":"2024","unstructured":"Cosma S, Ferraioli D, Borella F, Caretto M, Fuso L, Stura I, et al. Link between isolated para-aortic lymph node metastasis and intrauterine cancer site in early stage endometrial cancer. Int J Gynecol Cancer. 2024;34(12):1881\u20137. https:\/\/doi.org\/10.1136\/ijgc-2024-005769.","journal-title":"Int J Gynecol Cancer"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-04126-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-04126-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-04126-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:54:10Z","timestamp":1763549650000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-04126-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4126"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-04126-y","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Bursa Uluda\u011f University Clinical Research Ethics Committee (Protocol No. 2025\u2009\u2212\u2009800\/14\u201319). Due to the retrospective nature of the study, the ethics committee exempted the requirement for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"568"}}